MedPath

Histological Study to Assess Safety and Efficacy of the TempSure Firm for Non-Invasive Lipolysis

Not Applicable
Completed
Conditions
Non-invasive Lipolysis
Interventions
Device: TempSure Firm
Registration Number
NCT04878172
Lead Sponsor
Cynosure, Inc.
Brief Summary

This is a prospective, open-labeled, non-randomized, multi-center clinical study to collect safety and efficacy data on the TempSure Firm. The intended use of the TempSure device is to use the Firm handpieces for non-invasive lipolysis.

Detailed Description

Up to 12 subjects will be enrolled at up to 3 study centers. Subjects will attend a screening/pretreatment visit which may be performed on the same day as the treatment visit. Subjects may receive 1 treatment on the abdomen with the TempSure firm. Subjects will undergo abdominoplasty surgery at one of 4 predetermined timepoint after an abdomen treatment: day 0 (within 24 hours after treatment), 10 days (+/- 3 days), 20 days (+/- 3 days), or 30 days (+/- 7 days). This will be determined by the availability of the subject and/or an as needed basis and this will be decided by the Investigator and the Sponsor.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Male or female between 18 - 55 years old.
  • Willing to receive treatments with the TempSure® device and willing to have biopsies taken from a control site and the treatment area (biopsies are collected after the abdominal tissue flap is removed during abdominoplasty surgery)
  • Understand and accept obligation not to receive any other procedures on the treatment and control areas throughout the length of the study.
  • Understand and accept the obligation and able to be present for all study visits
  • Willing to comply with all requirements of the study and able to provide informed consent.
Exclusion Criteria

Pregnant or of childbearing potential and not using medically effective birth control, or has been pregnant in the last 3 months, currently breast feeding or planning to become pregnant prior to the end of the study.

  • Currently enrolled in an investigational drug or device trial, or has received an investigational drug or investigational device treatment(s) in the area to be treated (or designated control area) 6 months prior to entering this study (or at the discretion of the Investigator) .
  • Cuts, wounds, or infected skin on the area to be treated or designated control area
  • On local, oral, or systemic anesthetic agents.
  • Condition(s) or circumstance(s) that, in the investigators opinion, may put the subject at significant risk, may confound study results or may interfere significantly with subject participation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TempSure Firm Day 0 Biopsy GroupTempSure FirmSubjects will undergo abdominal surgery after an abdominal treatment with TempSure Firm at day 0 (within 24 hours after treatment).
TempSure Firm Day 10 Biopsy GroupTempSure FirmSubjects will undergo abdominal surgery after an abdominal treatment with TempSure Firm at day 10 (+/- 3 days) after treatment.
TempSure Firm Day 30 Biopsy GroupTempSure FirmSubjects will undergo abdominal surgery after an abdominal treatment with TempSure Firm at day 30 (+/- 7 days) after treatment.
TempSure Firm Day 20 Biopsy GroupTempSure FirmSubjects will undergo abdominal surgery after an abdominal treatment with TempSure Firm at day 20 (+/- 3 days) after treatment.
Primary Outcome Measures
NameTimeMethod
Histology of Biopsywithin 30 days (+/- 7 days) post treatment

Subjects will undergo abdominal surgery after an abdominal treatment with TempSure Firm at day 30 (+/- 3 days) after treatment. The samples were looked at from a qualitative standpoint to determine of whether the samples had signs of adipocyte injury and/or inflammatory tissue response, and if there was dermal/epidermal tissue injury (which was assessed by a qualified histologist).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Bass Plastic Surgery PLLC

🇺🇸

New York, New York, United States

Aesthetic Pavilion Ambulatory Surgery Center

🇺🇸

Staten Island, New York, United States

© Copyright 2025. All Rights Reserved by MedPath